Ozkan Sebiha, Murk William, Arici Aydin
Department of Obstetrics and Gynecology, Kocaeli University School of Mediine, Kocaeli, Turkey.
Ann N Y Acad Sci. 2008 Apr;1127:92-100. doi: 10.1196/annals.1434.007.
Endometriosis is an estrogen-dependent disorder defined as the presence of endometrial tissue outside of the uterine cavity. A leading cause of infertility, endometriosis has a prevalence of 0.5-5% in fertile and 25-40% in infertile women. The optimal choice of management for endometriosis-associated infertility remains obscure. Removal or suppression of endometrial deposits by medical or surgical means constitutes the basis of endometriosis management. Current evidence indicates that suppressive medical treatment of endometriosis does not benefit fertility and should not be used for this indication alone. Surgery is probably efficacious for all stages of the disease. Controlled ovarian hyperstimulation with intrauterine insemination is recommended in early-stage and surgically corrected endometriosis when pelvic anatomy is normal. In advanced cases, in vitro fertilization is a treatment of choice, and its success may be augmented with prolonged gonadotropin-releasing hormone analog treatment. Further randomized clinical trials focusing on diverse etiopathogenic mechanisms and therapeutic innovation are necessary to find more conclusive, evidence-based answers regarding this enigmatic disease.
子宫内膜异位症是一种雌激素依赖性疾病,定义为子宫腔外存在子宫内膜组织。子宫内膜异位症是导致不孕的主要原因之一,在育龄妇女中的患病率为0.5% - 5%,在不孕妇女中的患病率为25% - 40%。对于子宫内膜异位症相关不孕的最佳治疗选择仍不明确。通过药物或手术手段去除或抑制子宫内膜沉积物是子宫内膜异位症治疗的基础。目前的证据表明,子宫内膜异位症的抑制性药物治疗对生育没有益处,不应单独用于此适应症。手术可能对疾病的各个阶段都有效。当盆腔解剖结构正常时,对于早期和手术矫正后的子宫内膜异位症,建议采用控制性卵巢过度刺激联合宫腔内人工授精。在晚期病例中,体外受精是一种治疗选择,延长促性腺激素释放激素类似物治疗可能会提高其成功率。有必要开展更多聚焦于多种发病机制和治疗创新的随机临床试验,以找到关于这种神秘疾病更确凿的、基于证据的答案。